Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Essler

Showing results (161-170 of 208) with videos related to

Pageof 21
Sort By:
Epilepsia Open|January 19, 2023
The diagnostic value of ictal SPECT-A retrospective, semiquantitative monocenter studyFreya Schulte, Felix Bitzer, Florian Christoph Gärtner, et al.
Nuklearmedizin. Nuclear Medicine|December 1, 2025
Prognostic Significance of CD68+ Macrophages and FoxP3+ Regulatory T Cells in Neuroendocrine TumorsBarbara Kreppel, Jana Fink, Christine Sanders, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 4, 2022
Matched-pair analysis of [<sup>177</sup>Lu]Lu-PSMA I&T and [<sup>177</sup>Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancerPhilipp E Hartrampf, Franz-Xaver Weinzierl, Andreas K Buck, et al.
Frontiers in Oncology|August 12, 2022
Case Report: Sustained complete remission on combination therapy with olaparib and pembrolizumab in BRCA2-mutated and PD-L1-positive metastatic cholangiocarcinoma after platinum derivateTaotao Zhou, Robert Mahn, Christian Möhring, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 2, 2025
Bellmunt risk score enables survival prediction in men with metastatic castration resistant prostate cancer (mCRPC) undergoing PSMA-targeted radioligand therapy (LUMEN)Thomas Büttner, Milka Marinova, Florian C Gaertner, et al.
Frontiers in Immunology|January 7, 2025
Case report: Detecting giant cell arteritis in [<sup>68</sup>Ga]Ga-DOTA-Siglec-9-PET/CTSimon M Petzinna, Jim Küppers, Benedikt Schemmer, et al.
Scientific Reports|December 8, 2022
Improvement of fibroid-associated symptoms and quality of life after US-guided high-intensity focused ultrasound (HIFU) of uterine fibroidsTolga Tonguc, Florian Recker, Judith Ganslmeier, et al.
Oncology Letters|March 22, 2016
<sup>18</sup>F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case reportSied Kebir, Florian C Gaertner, Marcus Mueller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 23, 2014
Textural Parameters of Tumor Heterogeneity in ¹⁸F-FDG PET/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal CancerRalph A Bundschuh, Julia Dinges, Larissa Neumann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 25, 2017
α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer XenograftsSandra Heskamp, Reinier Hernandez, Janneke D M Molkenboer-Kuenen, et al.
Pageof 21

Showing results (161-170 of 208) with videos related to

Sort By:
Pageof 21
Epilepsia Open|January 19, 2023
The diagnostic value of ictal SPECT-A retrospective, semiquantitative monocenter studyFreya Schulte, Felix Bitzer, Florian Christoph Gärtner, et al.
Nuklearmedizin. Nuclear Medicine|December 1, 2025
Prognostic Significance of CD68+ Macrophages and FoxP3+ Regulatory T Cells in Neuroendocrine TumorsBarbara Kreppel, Jana Fink, Christine Sanders, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 4, 2022
Matched-pair analysis of [<sup>177</sup>Lu]Lu-PSMA I&T and [<sup>177</sup>Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancerPhilipp E Hartrampf, Franz-Xaver Weinzierl, Andreas K Buck, et al.
Frontiers in Oncology|August 12, 2022
Case Report: Sustained complete remission on combination therapy with olaparib and pembrolizumab in BRCA2-mutated and PD-L1-positive metastatic cholangiocarcinoma after platinum derivateTaotao Zhou, Robert Mahn, Christian Möhring, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 2, 2025
Bellmunt risk score enables survival prediction in men with metastatic castration resistant prostate cancer (mCRPC) undergoing PSMA-targeted radioligand therapy (LUMEN)Thomas Büttner, Milka Marinova, Florian C Gaertner, et al.
Frontiers in Immunology|January 7, 2025
Case report: Detecting giant cell arteritis in [<sup>68</sup>Ga]Ga-DOTA-Siglec-9-PET/CTSimon M Petzinna, Jim Küppers, Benedikt Schemmer, et al.
Scientific Reports|December 8, 2022
Improvement of fibroid-associated symptoms and quality of life after US-guided high-intensity focused ultrasound (HIFU) of uterine fibroidsTolga Tonguc, Florian Recker, Judith Ganslmeier, et al.
Oncology Letters|March 22, 2016
<sup>18</sup>F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case reportSied Kebir, Florian C Gaertner, Marcus Mueller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 23, 2014
Textural Parameters of Tumor Heterogeneity in ¹⁸F-FDG PET/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal CancerRalph A Bundschuh, Julia Dinges, Larissa Neumann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 25, 2017
α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer XenograftsSandra Heskamp, Reinier Hernandez, Janneke D M Molkenboer-Kuenen, et al.
Pageof 21